Deere & Company -- 5.6/10 -- $575.71
Gate result: All three YES. No cap applied. Score normally. Deere is a world-class industrial franchise with dominant market position, strong cash generation through the cycle, and a proven management team. The quality bar is met -- the question is valuation and timing.
| Dimension | Score | Weight | Weighted |
|---|---|---|---|
| Financial Trends | 5 | 25% | 1.25 |
| Thematic Exposure | 7 | 25% | 1.75 |
| Management Quality | 7 | 20% | 1.40 |
| Investor Sentiment | 4 | 15% | 0.60 |
| Concerns, Catalysts & Risks | 4 | 15% | 0.60 |
| Composite | 100% | 5.6 |
Deere & Company is the world-dominant agricultural equipment manufacturer headquartered in Moline, Illinois, operating across four segments: Production & Precision Ag (PPA, ~50-55% of revenue), Small Ag & Turf (SAT, ~20%), Construction & Forestry (C&F, ~20%), and Financial Services (~10%). Fiscal year ends October 31 (FQ1=Nov-Jan). FY2025 revenue was ~$45.7B, down 11.7% YoY in a cyclical ag downturn.
The bull case is a world-class franchise at a cyclical bottom. Deere holds ~45% of NA large ag equipment, forming a near-duopoly with CNH Industrial (~25%). Revenue is inflecting positive (FQ1 FY2026 +13% YoY) after a -30% trough. FCF remained $5.1B through the downturn. Precision ag technology (See & Spray, autonomous tractors, ExactApply) creates a recurring revenue overlay and deepens switching costs. Management delivered structural margin improvement of 450+ bps vs the prior cycle through proactive underproduction and inventory discipline. C&F order book is up +50%. The ag cycle is bottoming, and Deere is the highest-quality way to play the recovery.
The bear case is valuation and timing. At $575 and 30x forward P/E, the stock is 63% above ag peers CNH (~23x) and AGCO (~19x), and 68% above its own 10-year median of ~19x. The recovery is already priced in. CEO John May sold $20.8M in shares in January 2026 while publicly calling 2026 the bottom -- $49.8M total insider selling over 24 months with no meaningful buying. The precision ag thesis is consensus, not contrarian. Farm income is declining, China soybean purchases are running far below commitments, and a $1.2B tariff headwind looms in FY2026. Three consecutive years of earnings decline from $10.2B to ~$4.75B. Expected return is modestly negative at current price.
| Price | $575.71 | FY2025 Revenue | $45.7B (-11.7% YoY) |
| Market Cap | $155.5B | Operating Margin | ~13% (down from ~20% peak) |
| Enterprise Value | $213.4B | Free Cash Flow (FY25) | $5.1B |
| Forward P/E | 30.5x | EPS (TTM) | $17.74 |
| 52-Week Range | $404.42 - $674.19 | Dividend Yield | 1.13% |
| Beta | 0.99 | Short Interest | 1.61% |
DE receives a composite score of 5.6/10, reflecting strong thematic positioning (7) and management quality (7), middling financial trends (5) during a cyclical trough, and weak sentiment (4) and risk/valuation scores (4). All three quality gates PASS. The recommendation is Watchlist -- a world-class franchise at the wrong price.
Bull case (~$650-700, +13-22%): Ag cycle recovery accelerates through FY2026-2027. Revenue growth returns to high-single-digits. Precision ag monetization inflects with recurring revenue crossing $1B. Operating margins recover toward 18-20%. C&F infrastructure spending provides a second growth vector. Stock re-rates toward $700 on recovery earnings power of $25-28 EPS.
Base case (~$520-580, -10% to flat): Recovery is gradual and uneven. PPA remains soft in FY2026 while C&F and SAT recover modestly. Tariff headwinds offset volume recovery. Margins stabilize at 14-16%. Stock consolidates as the recovery thesis plays out slowly and the premium multiple compresses slightly.
Bear case (~$380-420, -26-34%): Farm income decline deepens. Trade war escalation hits export markets. Tariff burden exceeds $1.2B estimate. Recovery delayed to FY2028. Earnings trough extends. Multiple compresses to 20-22x (historical median), driving the stock to $380-420.
Bottom line: Deere is a generational franchise -- the kind of business you want to own for decades. But the stock at 30x forward P/E already discounts the cyclical recovery and precision ag upside. The CEO is selling, the thesis is consensus, and the valuation leaves no margin of safety. WATCHLIST at current levels. Would become a strong BUY on a pullback to $380-420 (20-22x forward P/E) where the quality franchise meets reasonable valuation.
Key catalysts and monitoring points:
- FQ2 FY2026 earnings (~May 14, 2026): Watch for revenue growth continuation after FQ1 +13% YoY. PPA segment guidance is down 5-10% for FY2026 -- any improvement would be a positive signal. Operating margin trajectory is critical.
- Precision ag recurring revenue: Technology-as-a-service monetization is still early and small vs the iron business. Watch for disclosure on See & Spray adoption rates, autonomous tractor fleet expansion, and recurring revenue as a percentage of PPA sales.
- Tariff resolution: $1.2B tariff headwind in FY2026. Any relief would be directly margin-accretive. Conversely, escalation would pressure an already compressed margin structure.
- Farm income trajectory: USDA net farm income forecasts are the leading indicator for equipment replacement cycles. Declining farm income = deferred purchases.
- Insider activity: CEO May sold $20.8M in January 2026. Any resumption of buying by senior management would be a meaningful signal. Continued selling at these levels reinforces the valuation concern.
- C&F order book: +50% and rising on infrastructure spending. This segment could partially offset PPA weakness and provides diversification away from ag cyclicality.
- Valuation entry point: At 20-22x forward P/E (~$380-420), the risk/reward profile shifts materially in favor of buyers. Monitor for any macro or sector-specific catalyst that could drive the stock toward this range.
For the full analysis, see the Business Model, Financials, Thematics, Management, Valuation, and Sentiment pages.